Ontology highlight
ABSTRACT:
SUBMITTER: de Wit L
PROVIDER: S-EPMC6701578 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
de Wit Leon L Rademaker Doortje D Voormolen Daphne N DN Akerboom Bettina M C BMC Kiewiet-Kemper Rosalie M RM Soeters Maarten R MR Verwij-Didden Marion A L MAL Assouiki Fahima F Schippers Daniela H DH Vermeulen Mechteld A R MAR Kuppens Simone M I SMI Oosterwerff Mirjam M MM Zwart Joost J JJ Diekman Mattheus J M MJM Vogelvang Tatjana E TE Gallas P Rob J PRJ Galjaard Sander S Visser Willy W Horree Nicole N Klooker Tamira K TK Laan Rosemarie R Heijligenberg Rik R Huisjes Anjoke J M AJM van Bemmel Thomas T van Meir Claudia A CA van den Beld Annewieke W AW Hermes Wietske W Vidarsdottir Solrun S Veldhuis-Vlug Anneke G AG Dullemond Remke C RC Jansen Henrique J HJ Sueters Marieke M de Koning Eelco J P EJP van Laar Judith O E H JOEH Wouters-van Poppel Pleun P Sanson-van Praag Marina E ME van den Akker Eline S ES Brouwer Catherine B CB Hermsen Brenda B BB Potter van Loon Bert Jan BJ van der Heijden Olivier W H OWH de Galan Bastiaan E BE van Leeuwen Marsha M Wijbenga Johanna A M JAM de Boer Karin K van Bon Arianne C AC van der Made Flip W FW Eskes Silvia A SA Zandstra Mirjam M van Houtum William H WH Braams-Lisman Babette A M BAM Daemen-Gubbels Catharina R G M CRGM Wouters Maurice G A J MGAJ IJzerman Richard G RG Mensing van Charante Nico A NA Zwertbroek Rolf R Bosmans Judith E JE Evers Inge M IM Mol Ben Willem BW de Valk Harold W HW Groenendaal Floris F Naaktgeboren Christiana A CA Painter Rebecca C RC deVries J Hans JH Franx Arie A van Rijn Bas B BB
BMJ open 20190818 8
<h4>Introduction</h4>In women with gestational diabetes mellitus (GDM) requiring pharmacotherapy, insulin was the established first-line treatment. More recently, oral glucose lowering drugs (OGLDs) have gained popularity as a patient-friendly, less expensive and safe alternative. Monotherapy with metformin or glibenclamide (glyburide) is incorporated in several international guidelines. In women who do not reach sufficient glucose control with OGLD monotherapy, usually insulin is added, either ...[more]